DDrare: Database of Drug Development for Rare Diseases

38. スティーヴンス・ジョンソン症候群
［臨床試験数：11，薬物数：19（DrugBank：8），標的遺伝子数：14，標的パスウェイ数：98］

Searched query = "Stevens-Johnson syndrome", "SJS", "Mucocutaneous ocular syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 0.05%cyclosporin eye drop; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine; Cultivated oral mucosal epithelial sheet transplantation; Cyclosporin; Cyclosporine; Cyclosporine 5 mg/kg bid days 0-14; Etanercept; Etanercept 50 mg sc day 0 and day 3; Harmonized supportive care; Infliximab; Intravenous immunoglobulin; Lamotrigine; Lamotrigine - generic product; Methylprednisolone; Palifermin; Prednisolone; Riboflavin; Site specific standard of care comparison; Topical infliximab

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01488396 (ClinicalTrials.gov)	February 2007	8/11/2010	Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye	Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye	Stevens-Johnson Syndrome	Drug: 0.05%cyclosporin eye drop	Mahidol University	NULL	Completed	18 Years	N/A	Both	31	Phase 4	Thailand

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01488396
(ClinicalTrials.gov)

February 2007

8/11/2010

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Stevens-Johnson Syndrome

Drug: 0.05%cyclosporin eye drop

Mahidol University

NULL

Completed

18 Years

N/A

Both

Phase 4

Thailand